Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
-
* Corresponding author: Susan F Hurley susanhurley@bainbridgeconsultants.com
Cost Effectiveness and Resource Allocation 2008, 6:12 doi:10.1186/1478-7547-6-12
Accesses
- Last 30 days: 68 accesses
- Last year: 832 accesses
- All time: 3885 accesses
Cited by
BioMed Central: 1 citation
|
Research
Cost-effectiveness of smoking cessation to prevent age-related macular degeneration Susan F Hurley, Jane P Matthews, Robyn H Guymer Cost Effectiveness and Resource Allocation 2008, 6:18 (11 September 2008) |
